Cargando…

1698. Trends in antimicrobial resistance among outpatient urine E. coli isolates in US females ≥12 years of age: A multicenter evaluation from 2011 to 2019

BACKGROUND: E. coli is the predominant uropathogen isolated in uncomplicated urinary tract infections (UTI). Surveillance data suggest increasing antimicrobial resistance (AMR), although recent data from the outpatient setting are limited. Treatment is typically empiric and should be guided by local...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kaye, Keith S, Gupta, Vikas, Mulgirigama, Aruni, Joshi, Ashish V, Scangarella-Oman, Nicole, Yu, Kalvin, Ye, Gang, Mitrani-Gold, Fanny S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Poster Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777775/ http://dx.doi.org/10.1093/ofid/ofaa439.1876

Ejemplares similares

187. Regional Distribution of Antimicrobial Resistance Among Outpatient Urine e. Coli Isolates in US Females ≥12 Years of age: a Multicenter Evaluation in 2019
por: Kaye, Keith S, et al.
Publicado: (2020)

1699. Variation of antimicrobial resistance by age groups for outpatient UTI isolates in US females: A multicenter evaluation from 2011 to 2019
por: Kaye, Keith S, et al.
Publicado: (2020)

2225. Analysis of Co-Resistance Among Escherichia coli Urine Isolates From Female Outpatients in the United States
por: Kaye, Keith S, et al.
Publicado: (2022)

Antimicrobial Resistance Trends in Urine Escherichia coli Isolates From Adult and Adolescent Females in the United States From 2011 to 2019: Rising ESBL Strains and Impact on Patient Management
por: Kaye, Keith S, et al.
Publicado: (2021)

2226. Analysis of Co-Resistance Among Klebsiella pneumoniae Urine Isolates From Female Outpatients in the United States
por: Kaye, Keith S, et al.
Publicado: (2022)

Older patient age and prior antimicrobial use strongly predict antimicrobial resistance in Escherichia coli isolates recovered from urinary tract infections among female outpatients
por: Mitrani-Gold, Fanny S., et al.
Publicado: (2023)

A systematic scoping review of faropenem and other oral penems: treatment of Enterobacterales infections, development of resistance and cross-resistance to carbapenems
por: Gandra, Sumanth, et al.
Publicado: (2022)

Richard Morton (1637-1698).
por: Trail, R R
Publicado: (1970)

Escherichia coli resistance, treatment patterns and clinical outcomes among females with uUTI in Germany: a retrospective physician-based chart review study
por: Naber, Kurt G., et al.
Publicado: (2023)

P19 Burden of illness and costs among female patients with uncomplicated urinary tract infection in England
por: Wilcox, Mark, et al.
Publicado: (2023)

P17 Baseline characteristics, disease progression rates and risk factors among female patients with uncomplicated urinary tract infection in England
por: Wilcox, Mark, et al.
Publicado: (2023)

P18 Treatment patterns and extent of inappropriate antimicrobial treatment among female patients with uncomplicated urinary tract infection in England
por: Wilcox, Mark, et al.
Publicado: (2023)

714. Analysis of the Effect of Urine on the In Vitro Activity of Gepotidacin and Levofloxacin Against Escherichia coli, Staphylococcus epidermidis, and Staphylococcus saprophyticus
por: Koeth, Laura M, et al.
Publicado: (2019)

2237. Enterbacterales Resistance Patterns for Extended-spectrum beta-lactamases (ESBL) Positive and Multidrug Resistance (MDR) Urine Isolates Collected and Tested from 295 Outpatient US Facilities in 2019
por: Rodriguez, Mauricio, et al.
Publicado: (2022)

1415. Allergies to Antimicrobial Agents Among US Females with Uncomplicated Urinary Tract Infection
por: Thompson, Jeffrey, et al.
Publicado: (2021)

Lunatic Asylum in the Workhouse: St Peter’s Hospital, Bristol, 1698–1861
por: Smith, Leonard
Publicado: (2017)

196. Activity Impairment and Health-Related Quality of Life Associated with an Uncomplicated Urinary Tract Infection Among US Females
por: Thompson, Jeffrey, et al.
Publicado: (2021)

123. Treatment Patterns and Prevalence of Inappropriate and Suboptimal Antibiotic Use Among Females with Uncomplicated Urinary Tract Infection in the US
por: Wang, Yuexi, et al.
Publicado: (2020)

194. Progression of an Uncomplicated Urinary Tract Infection Among Female Patients with Susceptible and Non-Susceptible Urine Isolates: Findings from an Integrated Delivery Network
por: Shafrin, Jason, et al.
Publicado: (2021)

Antifungal Susceptibility Profiles of 1698 Yeast Reference Strains Revealing Potential Emerging Human Pathogens
por: Desnos-Ollivier, Marie, et al.
Publicado: (2012)

186. A Systematic Literature Review on the Economic Burden of Illness in Gonorrhea
por: Martin, Amber, et al.
Publicado: (2020)

1358. A Real-World Study of the Burden of Illness and Treatment Patterns Among Patients with Uncomplicated Urogenital Gonorrhea in the United States
por: Preib, Madison T, et al.
Publicado: (2021)

1414. Real-World Study of Healthcare Resource Use and Costs Associated with Inappropriate and Suboptimal Antibiotic Use Among Females with Uncomplicated Urinary Tract Infection in the United States
por: Preib, Madison T, et al.
Publicado: (2021)

1227. A Survey Study of Healthcare Resource Use, and Direct and Indirect Costs, Among Females with an Uncomplicated Urinary Tract Infection in the United States
por: Thompson, Jeffrey, et al.
Publicado: (2021)

Activity impairment, health-related quality of life, productivity, and self-reported resource use and associated costs of uncomplicated urinary tract infection among women in the United States
por: Thompson, Jeffrey, et al.
Publicado: (2023)

Escherichia coli Resistance to Fluoroquinolones in Community-Acquired Uncomplicated Urinary Tract Infection in Women: a Systematic Review
por: Stapleton, Ann E., et al.
Publicado: (2020)

A multicenter analysis of trends in resistance in urinary Enterobacterales isolates from ambulatory patients in the United States: 2011–2020
por: Dunne, Michael W., et al.
Publicado: (2022)

1262. Antimicrobial Activity of Gepotidacin against Clinical Isolates of Escherichia coli and Staphylococcus saprophyticus Collected Worldwide in 2019
por: Arends, S J Ryan, et al.
Publicado: (2020)

Exercise-induced bronchoconstriction: prevalence, pathophysiology, patient impact, diagnosis and management
por: Aggarwal, Bhumika, et al.
Publicado: (2018)

Antimicrobial Activity of Gepotidacin Tested against Escherichia coli and Staphylococcus saprophyticus Isolates Causing Urinary Tract Infections in Medical Centers Worldwide (2019 to 2020)
por: Arends, S. J. Ryan, et al.
Publicado: (2023)

Economic burden of antibiotic-not-susceptible isolates in uncomplicated urinary tract infection: Analysis of a US integrated delivery network database
por: Shafrin, Jason, et al.
Publicado: (2022)

1698P The presence of COVID-19 makes more cancer patients distressed and time perception may distinguish them
por: Conev, N.V., et al.
Publicado: (2020)

P1698: INCREASED COMPLEMENT ACTIVATION AND DECREASED ADAMTS13 ACTIVITY IN PATIENTS WITH PRE-ECLAMPSIA COMPARED TO HEALTHY PREGNANCIES
por: Venou, T. M., et al.
Publicado: (2022)

1698. Activity of ceftolozane/tazobactam in vitro against Gram-negative isolates from pediatric patients: SMART 2017-2021
por: Mu, Xinli, et al.
Publicado: (2023)

Unmet needs in uncomplicated urinary tract infection in the United States and Germany: a physician survey
por: O’Brien, Megan, et al.
Publicado: (2023)

Trends in Streptococcus pneumoniae Antimicrobial Resistance in US Children: A Multicenter Evaluation
por: Mohanty, Salini, et al.
Publicado: (2023)

2159. Analysis of Resistance to Oral Standard-of-Care Antibiotics for Urinary Tract Infections Caused By Escherichia coli and Staphylococcus saprophyticus Collected in the United States in 2022
por: Arends, S J Ryan, et al.
Publicado: (2023)

1480. Plasma and Urine Pharmacokinetic Analysis of Gepotidacin (GSK2140944) Following BID Oral Dosing in a Phase IIa Study for Treatment of Uncomplicated Urinary Tract Infections
por: Zimmerman, Eric I, et al.
Publicado: (2019)

Using rapid point-of-care tests to inform antibiotic choice to mitigate drug resistance in gonorrhoea
por: Vegvari, Carolin, et al.
Publicado: (2020)

1440. Prevalence and Regional Variation of in ESBLs and CRE Enterobacteriaceae (ENT) among Adult, Hospitalized Patients with ENT on a Urine Culture: A Multicenter Evaluation
por: Lodise, Thomas, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_9ru4coiu5j4uprqnal4bt6kppd